Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors (Q34246966)

31 July 2017

title

Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors (English)

1 reference

31 July 2017

Manuela Bartolini

4

0 references

Vincenza Andrisano

object named as

Vincenza Andrisano

3

0 references

author name string

Maria Laura Bolognesi

1

1 reference

31 July 2017

Andrea Cavalli

2

1 reference

31 July 2017

Rita Banzi

5

1 reference

31 July 2017

Alessandra Antonello

6

1 reference

31 July 2017

Michela Rosini

7

1 reference

31 July 2017

Carlo Melchiorre

8

1 reference

31 July 2017

language of work or name

1 reference

1 September 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

58

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

917-928

1 reference

Genetic dissection of Alzheimer disease, a heterogeneous disorder

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Cholinergic drugs in pharmacotherapy of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Effects of acetylcholinesterase inhibitors on the metabolism of amyloid precursor protein in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Benzylamines: synthesis and evaluation of antimycobacterial properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

A new and rapid colorimetric determination of acetylcholinesterase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0014-827X(03)00150-2

10.1016/S0014-827X(03)00150-2

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference